Pharmafile Logo

responsive web design (RWD)

- PMLiVE

Zydus Cadila scores first ever NASH approval, in India

Drug has already been approved for diabetes related conditions

AstraZeneca AZ

AstraZeneca’s Imfinzi fails first-line bladder cancer test

Unable to improve overall survival in advanced metastatic bladder cancer

- PMLiVE

Trevena gets second go at FDA approval for pain drug

FDA sets review completion date of 7 August 2020

13th Edition – Spring MEDAFFAIRS Leaders Forum

OPEN VIE (Amanda Pulfer, Strategic Director and Sergio Diaz, Patient Centred Outcomes Consultant) were delighted to speak at the Medical Affairs Leaders Forum yesterday.

OPEN Health

- PMLiVE

Havas Life Medicom strengthens team with a host of hires

Agency grows its offering with 16 new hires

- PMLiVE

Takeda begins development of COVID-19 plasma therapy

Drug will harness the antibodies of recovered coronavirus patients

- PMLiVE

US piles pressure on Mallinckrodt over alleged Acthar fraud

Drugmaker allegedly underpaid rebates owed to Medicaid

- PMLiVE

Allergan and Editas claim a CRISPR first in inherited blindness study

Partners are first to use CRISPR to edit cells inside the body

- PMLiVE

Keytruda hits primary endpoint in confirmatory lymphoma trial

Interim analysis demonstrates improvement in progression-free survival

Roche Basel Switzerland

China backs use of Roche’s Actemra for coronavirus

Anti-inflammatory drug will be used in patients with lung complications

- PMLiVE

Q&A: Mike Dixon

PME interviews the CEO of the Healthcare Communications Association (HCA)

HARNESSING TECHNOLOGY TO TRANSFORM HEALTHCARE IN THE DIGITAL AGE

THE IMPACT OF TECHNOLOGY IN HEALTHCARECutting-edge technology is rapidly changing the healthcare landscape. When you look closely at the rate and level of innovation brought about by tech over the...

Say Communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links